Heidi Cuthbert

Viva Energy (ASX:VEA) reported a 154% increase in underlying EBITDA (RC) to $774.4 million for the half year ended June 30.

SkyCity Entertainment Group (ASX:SKC) declined two takeover proposals up to NZ$0.75 per share that undervalued the business.

VERAXA Biotech (NASDAQ:VRXA) and Secarna Pharmaceuticals announced a research milestone in their collaboration to develop antibody-oligonucleotide conjugates for autoimmune and chronic immune diseases.

Scinai Immunotherapeutics (NASDAQ:SCNI) reported first-half 2026 revenue of $949 thousand, up from $773 thousand a year earlier, driven mainly by its acquired Yavne contract development and manufacturing organization operations.

Gilead Sciences (NASDAQ:GILD) announced that the European Commission approved Trodelvy (sacituzumab govitecan-hziy) combined with Keytruda (pembrolizumab) for adults with PD-L1-positive metastatic triple-negative breast cancer.

X Financial (NYSE:XYF) reported second-quarter 2026 total net revenue of RMB993.6 million (US$146.4 million), marking a 56.3 percent year-over-year decline.

Arthur Hayes bought 1.9 million Ether.fi (CRYPTO:ETHFI) tokens worth about $1.17 million, according to Lookonchain.

City Chic Collective (ASX:CCX) reported global sales revenue of $130.5 million for the full year ended June 28.

Avalon Labs, a Bitcoin-focused on-chain finance platform, has added a new market-neutral yield pool to Super Earn.

Close the Loop (ASX:CLG) reported FY26 continuing operations revenue of $125.6 million, up 6% on the previous corresponding period.